UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
| Date of Report (Date of Earliest Event Reported): | January 19, 2006 (January 19, 2006) |
Endo Pharmaceuticals Holdings Inc.
(Exact name of registrant as specified in its charter)
| Delaware (State or other jurisdiction of incorporation) |
001-15989 (Commission File Number) |
13-4022871 (I.R.S. Employer Identification No.) |
||
100 Endo Boulevard, Chadds Ford, PA (Address of principal executive offices) |
19317 (Zip Code) |
|||
Registrant's telephone number, including area code (610) 558-9800
Not Applicable
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 7.01. Regulation FD Disclosure.
On January 19, 2006, Endo Pharmaceuticals Holdings Inc. filed an automatically effective shelf registration statement on Form S-3 with the Securities and Exchange Commission allowing for delayed offerings pursuant to Rule 415 of the General Rules and Regulations under the Securities Act of 1933, as amended, a copy of which is filed herewith as Exhibit 99.1 and is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
Not applicable.
Not applicable.
| Exhibit Number |
Description |
|
|---|---|---|
| 99.1 | Registration Statement on Form S-3, dated January 19, 2006 |
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
| ENDO PHARMACEUTICALS HOLDINGS INC. (Registrant) |
|||
By: |
/s/ CAROLINE B. MANOGUE Name: Caroline B. Manogue Title: Executive Vice President, Chief Legal Officer & Secretary |
||
Dated: January 19, 2006
| Exhibit No. |
Description |
|
|---|---|---|
| 99.1 | Registration Statement on Form S-3, dated January 19, 2006 |